Published in
Mary Ann Liebert, Antioxidants and Redox Signaling, 14(23), p. 1171-1185, 2015
Links
- ORCID
- Mary Ann Liebert
- ORCID
- [archive-ouverte.unige.ch] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [sro.sussex.ac.uk] | PDF
- [europepmc.org] | PDF
- [archive-ouverte.unige.ch] | PDF
Tools
Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications
Journal article published in 2015 by
Ana I. Casas,
V. Thao-Vi Dao,
Andreas Daiber,
Gus J. Maghzal,
Fabio Di Lisa,
Nina Kaludercic,
Sonia Leach,
Antonio Cuadrado,
Vincent Jaquet,
Tamara Seredenin,
Tamara Seredenina,
Karl-Heinz Krause,
Manuela Garcia Lopez 
,
Roland Stocker,
Pietro Ghezzi
and other authors.
,
Roland Stocker,
Pietro Ghezzi
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Enhanced levels of reactive oxygen species (ROS) have been associated with different disease states. Most attempts to validate and exploit these associations by chronic antioxidant therapies have provided disappointing results. Hence, the clinical relevance of ROS is still largely unclear.